Matthews International Capital Management LLC Next Cure, Inc. Transaction History

Matthews International Capital Management LLC

$468 Million
Q4 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 05, 2020	SELL	$8.15 - $21.17 $2.06 Million - $5.36 Million	-253,300 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$21.19 - $40.2 $2.82 Million - $5.36 Million	133,300 Added 111.08%	253,300 $5.43 Million
Q4 2019 Feb 04, 2020	SELL	$25.0 - $92.22 $7.44 Million - $27.5 Million	-297,695 Reduced 71.27%	120,000 $6.76 Million
Q3 2019 Nov 05, 2019	SELL	$15.73 - $41.6 $508,157 - $1.34 Million	-32,305 Reduced 7.18%	417,695 $12.9 Million
Q2 2019 Aug 06, 2019	BUY	$14.16 - $20.64 $6.37 Million - $9.29 Million	450,000 New	450,000 $6.74 Million

Others Institutions Holding NXTC

# of Institutions

Shares Held

14.6M

Call Options Held

Put Options Held

View Full List

About NextCure, Inc.

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $21.1M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

More about NXTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Matthews International Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Matthews International Capital Management LLC with notifications on news.

Account